{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:05:48Z","timestamp":1793023548448,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"42","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Gachon University Gil Medical Center","award":["2019-11"],"award-info":[{"award-number":["2019-11"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A5A2030333"],"award-info":[{"award-number":["NRF-2021R1A5A2030333"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>An increased risk of aortic aneurysm and aortic dissection (AA\/AD) has been reported with fluoroquinolone (FQ) use. However, recent studies suggested confounding factors by indication. This study aimed to investigate the risk of AA\/AD associated with FQ use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This nationwide population-based study included adults aged \u226520 years who received a prescription of oral FQ or third-generation cephalosporins (3GC) during outpatient visits from 2005 to 2016. Data source was the National Health Insurance Service reimbursement database. The primary outcome was hospitalization or in-hospital death with a primary diagnosis of AA\/AD. A self-controlled case series (SCCS) and Cox proportional hazards model were used. Self-controlled case series compared the incidence of the primary outcome in the risk period vs. the control periods.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 954 308 patients (777 109 with FQ and 177 199 with 3GC use) were included. The incidence rate ratios for AA\/AD between the risk period and the pre-risk period were higher in the 3GC group [11.000; 95% confidence interval (CI) 1.420\u201385.200] compared to the FQ group (2.000; 95% CI 0.970\u20134.124). The overall incidence of AA\/AD among the patients who received FQ and 3GC was 5.40 and 8.47 per 100 000 person-years. There was no significant difference in the risk between the two groups (adjusted hazard ratio 0.752; 95% CI 0.515\u20131.100) in the inverse probability of treatment-weighted Cox proportional hazards model. Subgroup and sensitivity analysis showed consistent results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>There was no significant difference in the risk of AA\/AD in patients who were administered oral FQ compared to those administered 3GC. The study findings suggest that the use of FQ should not be deterred when clinically indicated.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehad627","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T07:26:01Z","timestamp":1695108361000},"page":"4476-4484","source":"Crossref","is-referenced-by-count":18,"title":["Lack of association between fluoroquinolone and aortic aneurysm or dissection"],"prefix":"10.1093","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-3964","authenticated-orcid":false,"given":"Kyungmin","family":"Huh","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , 81 Irwon-ro, Gangnam-gu, Seoul 06351 , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9428-0258","authenticated-orcid":false,"given":"Minsun","family":"Kang","sequence":"additional","affiliation":[{"name":"Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University , 38-13, Dokjeom-ro 3beon-gil, Namdong-gu, Incheon 21565 , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4856-3668","authenticated-orcid":false,"given":"Jaehun","family":"Jung","sequence":"additional","affiliation":[{"name":"Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University , 38-13, Dokjeom-ro 3beon-gil, Namdong-gu, Incheon 21565 , Korea"},{"name":"Department of Preventive Medicine, Gachon University College of Medicine , 38-13, Dokjeom-ro 3beon-gil, Namdong-gu, Incheon 21565 , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"2023110920452467200_ehad627-B1","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey","volume":"6","author":"Versporten","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2023110920452467200_ehad627-B2","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2023110920452467200_ehad627-B3","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2023110920452467200_ehad627-B4","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the infectious diseases society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2023110920452467200_ehad627-B5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2023110920452467200_ehad627-B6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"key":"2023110920452467200_ehad627-B7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-0691.2005.01131.x","article-title":"Quinolones in 2005: an update","volume":"11","author":"Van Bambeke","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"2023110920452467200_ehad627-B8","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jamainternmed.2015.5389","article-title":"Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone","volume":"175","author":"Lee","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2023110920452467200_ehad627-B9","doi-asserted-by":"crossref","first-page":"k678","DOI":"10.1136\/bmj.k678","article-title":"Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study","volume":"360","author":"Pasternak","year":"2018","journal-title":"BMJ"},{"key":"2023110920452467200_ehad627-B10","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/jamainternmed.2020.4199","article-title":"Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection","volume":"180","author":"Gopalakrishnan","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2023110920452467200_ehad627-B11","author":"United States Food & Drug Administration"},{"key":"2023110920452467200_ehad627-B12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jamainternmed.2021.1154","article-title":"Association of US Food and Drug Administration removal of indications for use of oral quinolones with prescribing trends","volume":"181","author":"Tran","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2023110920452467200_ehad627-B13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jacc.2018.10.063","article-title":"Aortic aneurysm is not a rapidly expanding balloon","volume":"73","author":"Yin","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023110920452467200_ehad627-B14","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/jamainternmed.2020.4192","article-title":"Association of infections and use of fluoroquinolones with the risk of aortic aneurysm or aortic dissection","volume":"180","author":"Dong","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2023110920452467200_ehad627-B15","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/STROKEAHA.119.028490","article-title":"Risk of intracranial aneurysm and dissection and fluoroquinolone use: a case-time-control study","volume":"51","author":"Maumus-Robert","year":"2020","journal-title":"Stroke"},{"key":"2023110920452467200_ehad627-B16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023267","article-title":"Association between aortic aneurysm and aortic dissection with fluoroquinolones use in patients with urinary tract infections: a population-based cohort study","volume":"11","author":"Chen","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2023110920452467200_ehad627-B17","author":"United States Food & Drug Administration"},{"key":"2023110920452467200_ehad627-B18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"2023110920452467200_ehad627-B19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2018.06.067","article-title":"Oral fluoroquinolone and the risk of aortic dissection","volume":"72","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023110920452467200_ehad627-B20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00708-21","article-title":"Fluoroquinolone prescribing for diabetic foot infections following an FDA drug safety communication for aortic aneurysm risk","volume":"65","author":"Li","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2023110920452467200_ehad627-B21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2018.12.012","article-title":"Short-term risk of aortoiliac aneurysm or dissection associated with fluoroquinolone use","volume":"73","author":"Maumus-Robert","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023110920452467200_ehad627-B22","doi-asserted-by":"crossref","first-page":"e00664","DOI":"10.1002\/prp2.664","article-title":"Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: a self-controlled case series analysis","volume":"8","author":"Aspinall","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"2023110920452467200_ehad627-B23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamasurg.2020.6165","article-title":"Association of fluoroquinolone use with short-term risk of development of aortic aneurysm","volume":"156","author":"Newton","year":"2021","journal-title":"JAMA Surg"},{"key":"2023110920452467200_ehad627-B24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12872-022-02488-x","article-title":"Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case-control study","volume":"22","author":"Son","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"2023110920452467200_ehad627-B25","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/art.10617","article-title":"Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy","volume":"46","author":"Corps","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023110920452467200_ehad627-B26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jor.21196","article-title":"Ciprofloxacin up-regulates tendon cells to express matrix metalloproteinase-2 with degradation of type I collagen","volume":"29","author":"Tsai","year":"2011","journal-title":"J Orthop Res"},{"key":"2023110920452467200_ehad627-B27","doi-asserted-by":"crossref","first-page":"11073","DOI":"10.1038\/s41598-021-90692-8","article-title":"The association between fluoroquinolones and aortic dissection and aortic aneurysms: a systematic review and meta-analysis","volume":"11","author":"Wee","year":"2021","journal-title":"Sci Rep"},{"key":"2023110920452467200_ehad627-B28","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1093\/cid\/cis370","article-title":"IDSA Clinical practice guideline for acute bacterial rhinosinusitis in children and adults","volume":"54","author":"Chow","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2023110920452467200_ehad627-B29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/21681805.2021.1916072","article-title":"Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study","volume":"55","author":"Lundstrom","year":"2021","journal-title":"Scand J Urol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/42\/4476\/53000602\/ehad627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/42\/4476\/53000602\/ehad627.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T20:45:50Z","timestamp":1699562750000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/44\/42\/4476\/7276812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":29,"journal-issue":{"issue":"42","published-online":{"date-parts":[[2023,9,19]]},"published-print":{"date-parts":[[2023,11,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehad627","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,7]]},"published":{"date-parts":[[2023,9,19]]}}}